Page 6 - Pharma Stocks

Biocon share price pops 2% on CDSCO nod for diabetes drug; key details here

Biocon's share price saw an uptick following key regulatory approvals in India for its Liraglutide drug, which is used in the treatment of type 2 diabetes.

AstraZeneca Pharma rises 2% on securing CDSCO nod for Benralizumab solution

AstraZeneca Pharma shares rose on receiving nod from the CDSCO, to import for sale and distribution of Benralizumab 30 mg/ml solution for injection (brand name: Fasenra) for an additional indication.

Concord Biotech share price pops 6% on healthy Q4 nos; profit zooms 48% YoY

Concord Biotech share price rose on the back of a healthy March quarter of financial year 2025 (Q4FY25) results.

Here's why Natco Pharma share price is buzzing in trade on Thursday, May 29

Natco Pharma share price rose on the back of a healthy March quarter of financial year 2025 (Q4FY25) results.

These 5 pharma stocks can fall up to 12% as technical charts flag caution

Abbott India, Aurobindo Pharma, Cipla, Dr Lal PathLabs and Torrent Pharma flag caution signals on technical charts; here are the key levels to watch out for.

Bajaj Healthcare slips 9% on weak Q4 operational performance; details here

Bajaj Healthcare share price dropped today on the back of weak operational performance in the March quarter of FY25 (Q4FY25).

Divi's Labs share up 4%, hits record high on inking supply deal; details

Divi's Laboratories share price rose after the company announced that it has inked a long-term manufacturing and supply agreement with a global pharmaceutical company.

What drove Indoco Remedies share price 6% higher today? Top details inside

Indoco Remedies' share price rose after the company received final USFDA approval for its ANDA to market Allopurinol tablets USP, 200 mg - a generic version of Zyloprim 200 mg by Casper Pharma LLC.

Sensex rises 410 pts, Nifty tops 24,800; analysts foresee 'sell on rallies'

The Sensex settled at 81,596.63, up 410.19 points or 0.51 per cent, while the Nifty50 closed at 24,813.45, gaining 129.55 points or 0.52 per cent

Zydus Life Q4 profit falls 1% YoY; ₹11 dividend declared; stock down 2%

Zydus Lifesciences consolidated net profit slipped about 1 per cent year-on-year (Y-o-Y) to ₹1,171 crore in the March quarter of financial year 2025 (Q4FY25), from ₹1,182 crore in Q4FY24.

Sun Pharma Q4 preview: Analysts expect 18% jump in profit; check details

Sun Pharma Q4 results date: Sun Pharma is scheduled to announce its fourth quarter results on Thursday, May 22, 2025

Pfizer share climbs 11% post healthy Q4; announces Rs 165 dividend for FY25

Pfizer shares climbed after the company reported a strong set of March quarter results on May 19, 2025.

Piramal Pharma stock falls 5% after Q4 results; check key numbers here

Piramal Pharma stock was down 4.5 per cent at ₹209 compared to the previous day's close of ₹219.04 on the NSE

Here's why Marksans Pharma share price increased over 2% in trade on May 15

At 11:20 PM, Marksans Pharma shares pared gains and were trading merely 0.08 per cent higher at Rs 238 per share. In comparison, BSE Sensex was trading 0.10 per cent lower at 81,247.08 level.

Lupin shares gain 4% on Tolvaptan Tablets launch in US; details here

Lupin, in a release, said that it holds the exclusive first-to-file status for this product and will have 180-day generic drug exclusivity

Dr Reddy's: Brokerage reports by JM Financial, Motilal Oswal as stock up 4%

DRL's management has guided for double-digit growth in FY26, with margins expected to remain similar to FY25 levels. Here's what brokerages expect from the company going ahead

Dr Reddy's Q4 results preview: Analysts eye 18% jump in PAT; check details

Dr Reddy's Labs Q4 results 2025 date: Dr Reddy's Laboratories is scheduled to announce its fourth quarter (Q4FY25) results on Friday, May 9, 2025

Blue Jet Healthcare jumps 6% as MOFSL initiates coverage, 26% upside seen

Blue Jet Healthcare's stock was quoting at ₹715, up 4.32 per cent on the National Stock Exchange

Mutual Funds increased stake in 14 pharma stocks in Q4FY25; do you own any?

Analysts believe that pharma shares continue to see buying interest, given the inelastic demand for medicines; tariffs, if any could have minimal impact on the industry.

These 3 pharma stocks have surged over 50% in April; check full list here

A total of 11 pharma and healthcare-related stocks have rallied more than 20% thus far in April on hopes of a likely softer tariff-related stance by the US President Donald Trump.